SOX2 and cancer: The C/D box snoRNA SNORD1C was highly expressed in CRC to enhance cancer cell stemness and 5-FU resistance via the Wnt/β-catenin pathway, resulting in downregulation of c-Myc downstream, as well as other stem cell regulatory genes, such as CD44 and SOX2 [182].